The FTC is attacking drugmakers’ ‘patent thickets’

The FTC is attacking drugmakers’ ‘patent thickets’

Source: 
Medical Marketing and Media
snippet: 

The Federal Trade Commission has challenged the validity of over 100 drug product patents in an effort to increase competition and potentially lower some prices.